As a particular focus was given to the expressional status of FRMD5 in BRAF-mutated PTCs, an analysis of FRMD5 activation status was performed on the BRAF-like molecular subtype of PTC and compared with other TC types and non-tumor (control) specimens. Here, FRMD5 is linked to neoplasm.